Clinical Trial Update: A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bortezomib as consolidation therapy in multiple myeloma has completed; the update does not provide trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Janssen-Cilag G.m.b.H | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED